Company intelligence / Profile preview

Dermala

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Dermala offers FDA-approved personalized OTC kits using microbiome modulation (probiotics, prebiotics, postbiotics) for acne, supported by clinical trials and customer reviews showing skin and digestion improvements.[3][5]

Therapeutic areas: Dermatology
Modalities: ProbioticPrebioticPostbiotic
Industry: Biotech

Drug pipeline

7 assets

SUPPLEMEANT to Be DIM Skin Mix

Unknown

6 more assets in the full pipeline.

Request access →

Partnerships

Johnson & Johnson Innovation (JLABS incubator)

Beyond the preview

Go deeper on Dermala.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermala.

Explore the full profile